Radiotherapy-activated nbtxr3 nanoparticles modulate cancer cell immunogenicity and tcr repertoire

HIGHLIGHTS

• who: Audrey Darmon from the Nanobiotix, France have published the paper: Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire, in the Journal: (JOURNAL)
• what: To evaluate this possibility, the authors focused the analyses on peptides of the groups RT and NBTXR3 + RT and RT vs. NBTXR3 + RT displaying a Log2 > 1. The authors identified the subcellular location of corresponding proteins, based on information collected on Uniprot Knowledgebase (GO-Cellular component) (Fig 4A-D) .
• how: Methods To identify the mechanisms that may explain this response the authors evaluated the capacity of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.